Immunoprecipitation enrichment has significantly improved the sensitivity and accuracy of detecting RNA modifications in the transcriptome. However, there are no existing methods for selectively isolating adenosine-to-inosine (A-to-I) edited RNAs. Here we show that Escherichia coli Endonuclease V (eEndoV), an inosine-cleaving enzyme, can be repurposed to bind and isolate A-to-I edited transcripts from cellular RNA through adjustment of cationic conditions. While Mg 2+ is required for eEndoV catalysis, it has also been shown that similar levels of Ca 2+ instead promote binding of inosine without cleavage. Leveraging these properties, we observe that Ca 2+ -supplemented eEndoV is highly specific for inosine in RNA and exhibits low nanomolar binding affinity. We then demonstrate EndoVIPER (Endonuclease V inosine precipitation enrichment) as a facile and robust method to isolate A-to-I edited transcripts from cellular RNA. We envision the use of this approach as a straightforward and cost-effective strategy to enrich edited RNAs and detect A-to-I sites with improved sensitivity and fidelity.
1
Enriching A-to-I edited transcripts from total RNA prior to analysis would largely overcome 2 these challenges by depleting unedited RNAs that otherwise lead to "wasted" sequencing 3 reads. Similar approaches for pulldown of modified bases has markedly improved the 4 throughput and reliability in detecting several other epitranscriptomic and epigenetic 5 modifications. Of note, immunoprecipitation (IP) of RNA and DNA using antibodies for N 6 -6 methyladenosine and 5-methylcytosine, respectively, has significantly reduced sample 7 complexity prior to analysis, in turn drastically improving detection fidelity, sensitivity, and 8 overall throughput. [11] [12] While a previous report detailed the generation of inosine-9
targeting polyclonal antibodies for enriching modified tRNAs, these were also found to 10 cross-react with several other nucleobases, and this method has not been reproduced. 13 
11
We previously explored chemical labeling and enrichment of inosine using an acrylamide 12
derivative, and while we demonstrated feasibility in modification and capture of inosine-13
containing RNAs, this method also displayed off-target reactivity with pseudouridine and 14 uridine, limiting the enrichment efficiency. 14 Currently, there are no robust methods for 15 the affinity purification of inosine-containing transcripts. Herein we report EndoVIPER 16
(Endonuclease V inosine precipitation enrichment) as a novel method to selectively enrich 17
A-to-I edited transcripts. EndoVIPER leverages the observation that supplementation of 18 the enzyme with Ca 2+ promotes binding rather than cleavage of A-to-I transcripts, 19
enabling their isolation. We employ this technique in a magnetic immunoprecipitation 20 workflow, validating EndoV specificity and efficiency in binding inosine in RNA. We then 21 demonstrate EndoVIPER in enriching an A-to-I edited coding transcript from human brain 22 cellular RNA, highlighting the utility of this approach to study A-to-I RNA editing in 23 biological contexts.
25
Results 26 27
Endonuclease V specifically recognizes inosine in RNA and exhibits robust binding 28
in the presence of Ca 2+ 29 30
Due to the previously reported difficulties in developing inosine-targeting antibodies, we 31
instead searched for naturally-occurring proteins capable of recognizing and binding to 32 inosine. We identified EndoV, a highly conserved nucleic acid repair enzyme found in all 33
domains of life. In prokaryotes, EndoV is mainly responsible for detection of inosine 34
resulting from oxidative damage in DNA, and cleaves after these deamination lesions to 35 promote base excision repair. 15 In humans and other metazoans, EndoV has been 36 implicated in the metabolism of A-to-I edited RNAs. [16] [17] Thus, we hypothesized that if the 37 cleavage activity could be selectively suppressed without compromising recognition and 38
binding, then EndoV could be leveraged for enriching A-to-I edited RNAs. While human 39
EndoV (hEndoV) appears to be a good candidate toward this goal, recent studies also 40 identified variable substrate preferences and possible affinity toward both unedited 41 double-stranded RNA (dsRNA) and ribosomal RNA (rRNA), properties which could be 42
problematic for use in total RNA samples. 18 Interestingly, these reports also showed that 43
Escherichia coli EndoV (eEndoV) was both specific and highly active toward inosine in 44 single-stranded RNA (ssRNA) and exhibited minimal substrate or sequence bias. 16-17 45 These observations, as well as the commercial availability of a purified recombinant 46 enzyme, encouraged us to explore eEndoV for the pulldown and enrichment of A-to-I 1 edited transcripts. 
11
Structural analyses of several orthologs have revealed that EndoV requires Mg 2+ as a 12
cofactor for inosine recognition and catalysis of strand scission ( Fig. S1 ). 19 Similar studies 13 have also found that replacing Mg 2+ with Ca 2+ facilitates binding of EndoV to inosine 14
substrates, yet does not support catalysis. 20 While the exact mechanism underlying this 15 observation is unknown, it is likely that differences in electronics and coordination 16 chemistry between the two metals are key factors. In any case, we hypothesized that 17
supplementing eEndoV with Ca 2+ would enable enrichment of inosine-containing RNAs 18 ( Fig. 1a ). To test this, we synthesized a pair of Cy5-labeled oligoribonucleotides having 19 either A or I in a defined position, and evaluated eEndoV activity in the presence of both 20
cations. Consistent with previous reports, we observed not only specific cleavage activity 21 towards inosine in ssRNA (RNA I) when benchmarked against a non-edited control (RNA 22
A), but also an obligate Mg 2+ requirement for cleavage ( Fig. S2 ). We next sought to 23 evaluate the effect of Ca 2+ supplementation on the ability of eEndoV to bind and isolate 24
inosine-containing ssRNA. Conveniently, the recombinant enzyme is genetically fused to 25 a maltose-binding protein (MBP) tag, enabling us to design a magnetic IP workflow using 26
anti-MBP functionalized beads, which we term EndoVIPER (Endonuclease V inosine 27 precipitation enrichment, Fig. 1b ). Using this method, we attempted pull down of both 1 RNA A and RNA I in the presence of variable amounts of Ca 2+ , monitoring the initial, 2 unbound (flowthrough) and elution fractions after washing ( Fig. 1c, S3 ). Not surprisingly, 3
omitting Ca 2+ produced little binding of either oligonucleotide, corroborating the notion 4
that Mg 2+ aids in both recognition and cleavage of inosine substrates. Increasing amounts 5
of Ca 2+ from 0-10 mM improved binding efficiency substantially, approaching ~80% 6 recovery with excellent selectivity (~350-fold over pulldown of RNA A). Interestingly, 7
additional supplementation beyond 10 mM Ca 2+ quickly decreased pulldown efficiency 8
and selectivity ( Fig. 1c-d, S2 ). While unconfirmed, these results may arise from 9 electrostatic shielding of the negative charge of the phosphodiester backbone, preventing 10 key amino acid residues from interacting with the nucleic acid substrate. Regardless, we 11
identified 5 mM Ca 2+ as ideal for maximizing recovery and selectivity, and moved forward 12
with measuring the binding affinity of eEndoV for both RNA substrates using microscale 13 thermophoresis (MST). Consistent with our IP results, we observed low nanomolar affinity 14
for RNA I and no measurable binding to the off-target control (Fig 1e, S3) . 15 16
EndoVIPER enables enrichment of A-to-I edited transcripts from cellular RNA 17 18
Encouraged by these results, we challenged our EndoVIPER protocol to enrich a naturally 19 edited transcript from cellular RNA ( Fig. 2a ). To assess enrichment efficiency, we chose 20
to track the GRIA2 mRNA, an ionotropic glutamate receptor transcript that is highly edited 21 in the brain. 9 (Fig. 2b) . We designed primers flanking the Q607R A-to-I recoding site and 22
used quantitative polymerase chain reaction (qPCR) to measure enrichment of the 23 amplicon. We observed ~45-fold enrichment of GRIA2 from human brain mRNA 24 compared to a mock magnetic bead control. However, when we applied this method in 25 brain total RNA, we observed a nearly 10-fold drop in GRIA2 enrichment efficiency ( Fig  26  2c) . We speculate this could be due to significantly higher content of other A-to-I edited 27
transcripts that were quenching our pulldown. In particular, ~7-8 human tRNAs contain 28 inosine at the wobble N34 position. Additionally, A-to-I sites have been identified in 29 ribosomal RNA (rRNA). 21 In either case, edited tRNA and rRNA would constitute a large 30 molar proportion of our total RNA sample and potentially saturate the eEndoV binding 31 sites. 22 Regardless, we still observe statistically significant enrichment (~5-fold) of GRIA2 32 from total RNA, demonstrating the method's compatibility and efficacy in complex RNA 33
samples. Together, these experiments show that EndoVIPER is capable of selectively 34
isolating inosine-containing transcripts with high efficiency. 35 Discussion 7 8
Herein we present EndoVIPER as a new method for the affinity pulldown of inosine-9
containing transcripts from RNA, overcoming existing limitations in the detection and 10 characterization of A-to-I RNA editing in complex biological samples. Our approach is 11 robust, displaying high affinity and selectivity for inosine in RNA. In addition, EndoVIPER 12 exclusively utilizes low-cost, commercially available reagents with little to no modification. 13
Further, this method is compatible with both purified and total cellular RNA, and fits well 14 with existing library preparation protocols for both lower throughput analyses as well as 15
next-generation RNA-seq. 16 17
While this study establishes a novel workflow for A-to-I enrichment, there remains 18 opportunity for further improving EndoVIPER efficiency and selectivity. As described 19
previously, EndoV is present across nearly all domains of life, offering a vast array of 20 potential affinity scaffolds for use in subsequent iterations of this method. In addition, this 21 approach could be further elaborated by in-depth protein engineering and directed 22 evolution strategies to increase binding affinity and tune EndoVIPER selectivity for 23 specialized sequence contexts or sample types. Further, a wide variety of purification tags 24 and bioconjugation chemistries are available for affinity enrichment of biomolecules, 25 offering additional avenues for optimization of this workflow. We anticipate that the overall 1 ease of use and accessibility of this method will find utility in a number of empirical 2 contexts, significantly improving our understanding of the dynamics and regulation of A-3
to-I RNA editing in a range of biological settings, in turn elucidating its role in normal 4 cellular processes and its relationship with disease pathology. 5
Methods 1 2 RNA Oligoribonucleotides 3 4
All oligonucleotides used in this study were custom designed and purchased from 5
Integrated DNA Technologies. Edited and non-edited controls were synthesized with a 6
Cyanine5 (Cy5) label at the 5' terminus as shown below. 7 8
RNA I 5' Cy5 AAGCAGCAGGCUIUGUUAGAACAAU 3' 9 10
RNA A 5' Cy5 AAGCAGCAGGCUAUGUUAGAACAAU 3' 11 12
RNA Cleavage Assays 13 14
10 pmol of either RNA I or RNA A was incubated in the presence or absence of both 15
Mg 2+ at a 10 mM final concentration and/or 9pmol recombinant eEndoV (New England 16
Biolabs) in a total volume of 10 µL. Final buffer conditions in all reactions were 10 mM 17
Tris, 125 mM NaCl, 15 µM EDTA, 150 µM DTT, 0.025% Triton X-100, 30 µg/ml BSA, 18
7% glycerol, pH 7.4. Reactions were incubated for 1 hour at 25 ºC, followed by a 10 min 19
heat inactivation at 85ºC. Reaction products were separated using 10% denaturing 20 PAGE, and gels were imaged with a GE Amersham Typhoon RGB scanner using 635 21 nm excitation laser and the Cy5 670BP30 emission filter.
23
EndoVIPER Magnetic IP Assays 24 25
For each binding test, 10 pmol of either RNA I or RNA A was combined with 30 pmol of 26 eEndoV and variable amounts of CaCl2 (0, 0.1, 0.5, 1, 2.5, 5, 10 and 20 mM) in a total 27 volume of 50 µL. Final buffer conditions were 10 mM Tris, 125 mM NaCl, 15 µM EDTA, 28
150 µM DTT, 0.025% Triton X-100, 30 µg/ml BSA, 7% glycerol, pH 7.4. Reactions were 29 incubated at 25 ºC for 30 min, after which a 3 µL sample (initial, I) was taken and set 30 aside for later analysis. Separately, 70 µL of anti-MBP magnetic bead slurry (New 31
England Biolabs) was washed extensively with a buffer containing 10 mM Tris, 125 mM 32
NaCl, 7% glycerol, and variable amounts of CaCl2 (0, 0.1, 0.5, 1, 2.5, 5, 10 and 20 mM), 33 pH 7.4. After washing, beads were resuspended in eEndoV-RNA samples and incubated 34
at 25 ºC for two hours with end-over-end rotation. Magnetic field was applied to beads 35 and a 3 µL sample (unbound, UB) of the supernatant was saved for later analysis. Beads 36
were washed extensively with respective buffers containing variable amounts of Ca 2+ , 37
and resuspended in 50 µL 10 mM Tris, 125 mM NaCl, 0. with a buffer containing 10 mM Tris, 125 mM NaCl, 5 mM CaCl2, and 7% glycerol, pH 7.4. 21
After washing, beads were resuspended in eEndoV-RNA samples and incubated at 25 22 ºC for two hours with end-over-end rotation. Beads were then washed extensively with 23 10 mM Tris, 125 mM NaCl, 5 mM CaCl2, and 7% glycerol, and resuspended in nuclease 24 free water. Beads were heated to 95 ºC for 20 min. Magnetic field was applied and the 25 supernatant was collected, 0.2 µm filtered, and ethanol precipitated. The RNA pellets 26
were then resuspended in 6 µL nuclease free water, mixed with 20 pmol of GRIA2 reverse 27 primer (5' CCACACACCTCCAACAATGCG 3'), heated to 70 ºC for 10 min, and cooled 28 on ice for 5 min. First strand cDNA synthesis was performed for one hour at 42 ºC using 29 M-MuLV Reverse Transcriptase (New England Biolabs). Reactions were then mixed with 30 10 pmol of GRIA2 forward primer (5' GGGATTTTTAATAGTCTCTGGTTTTCCTTGGG 3') 31
and reverse primer and 1X iTaq Universal SYBR Green Supermix (BioRad 
